This presentation shows that they are listening to
Post# of 15624
(Total Views: 478)
Posted On: 11/12/2017 1:57:19 PM
Re: Greekboxer #11414
This presentation shows that they are listening to shareholders even though they might not be responding to the bitching and are actually focusing on getting it done.
A few things I noted:
1. Cream- There is a Pharmaceutical and Medical Cannabis (OTC/Cosmetic type) application. It appears the Cosmetic is ready for distribution (OWCP previously previously stated it was Market Ready... Which means developed and if you look at their developed slide they project 2-4 million/month after 3 years from launch) and the Pharmaceutical cream will be going to phase 2 but it's VERY nice to see their timelines to the quarter and that will be a huge revenue driver that they project being worth 1 billion in revenue per year.
2. COMPLETELY DEBT FREE and FUNDED THROUGH Q2 2018.
3. For I-glow they gave their amount they are spending on research broken down by quarter (Refer to research costs in Israel vs US for why it's not 100s of millions)
4. Quarterly burn rate is about 300k and expecting to end 2017 with 750k cash on hand. (Translation... Don't expect we will need money until start of Q3 2018)
5. And most importantly "Additional MOUs in Canada – in negotiation"= More MONEY
Essentially MedMar stated they would have product on shelves anyday now...OWCP just gave us the project revenue of 2-4 million per year after 3 years of being on the market and that other MOUs are in the work....
So yes... anyone who lets this go for less than 2 bucks tomorrow is a silly. OWCP will soon be SELF FUNDING- (Revenue at 2Million per month is equal to 24 million per year (Look how low our research cost are) and then you have to factor in your multiplier which is typically 10 to 20 percent for biopharma companies but MMJ Biopharma companies are trading for a 60x plus multiplier right now on the Canadian Market...
Oh by the way... Canadian Cross list in 2 weeks. tops.
THEY JUST TOLD US WE ARE GOING TO BE MILLIONAIRES From this level in and basically confirmed over 5 bucks a share in months.
A few things I noted:
1. Cream- There is a Pharmaceutical and Medical Cannabis (OTC/Cosmetic type) application. It appears the Cosmetic is ready for distribution (OWCP previously previously stated it was Market Ready... Which means developed and if you look at their developed slide they project 2-4 million/month after 3 years from launch) and the Pharmaceutical cream will be going to phase 2 but it's VERY nice to see their timelines to the quarter and that will be a huge revenue driver that they project being worth 1 billion in revenue per year.
2. COMPLETELY DEBT FREE and FUNDED THROUGH Q2 2018.
3. For I-glow they gave their amount they are spending on research broken down by quarter (Refer to research costs in Israel vs US for why it's not 100s of millions)
4. Quarterly burn rate is about 300k and expecting to end 2017 with 750k cash on hand. (Translation... Don't expect we will need money until start of Q3 2018)
5. And most importantly "Additional MOUs in Canada – in negotiation"= More MONEY
Essentially MedMar stated they would have product on shelves anyday now...OWCP just gave us the project revenue of 2-4 million per year after 3 years of being on the market and that other MOUs are in the work....
So yes... anyone who lets this go for less than 2 bucks tomorrow is a silly. OWCP will soon be SELF FUNDING- (Revenue at 2Million per month is equal to 24 million per year (Look how low our research cost are) and then you have to factor in your multiplier which is typically 10 to 20 percent for biopharma companies but MMJ Biopharma companies are trading for a 60x plus multiplier right now on the Canadian Market...
Oh by the way... Canadian Cross list in 2 weeks. tops.
THEY JUST TOLD US WE ARE GOING TO BE MILLIONAIRES From this level in and basically confirmed over 5 bucks a share in months.
(5)
(0)